CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a new trial coordinator. The “first-in-class” platform will address the top ...
The complex task of managing clinical trial finances is generally accepted as a cost of doing business in the pharmaceutical industry. But today, higher costs and ongoing pressures to shorten study ...
ALS — also often called Lou Gehrig’s disease — is a progressive, neurodegenerative disease with no cure. Despite its devastating impact, the pace of new therapy development has remained sluggish — ...
The Association has now committed £1.5 million over five years to MND-SMART, increasing its contribution from the £0.5 ...
ATLANTA, GEORGIA / ACCESS Newswire / October 28, 2025 / Florence Healthcare, the leading clinical trial platform connecting pharmaceutical sponsors and research sites worldwide, announced today that ...
In the Phase 2 Study of TPN-101 in patients with C9orf72-related ALS, TPN-101 showed clinical benefits on key clinical outcome measures, including slow vital capacity and the ALSFRS-R TPN-101 also had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results